The effect of defective early phase insulin secretion on postload glucose intolerance in impaired fasting glucose

Endocrine Journal

Volumn 52, Issue 5, 2005, Pages 531-536

  Sargin, Mehmet ^a,b   Ikiişik, Murat ^a   Sargin, Haluk ^a   Orçun, Asuman ^a   Kaya, Müjgan ^a   Gözü, Hülya ^a   Dabak, Reşat ^a   Bayramiçli, Oya Uygur ^a   Yayla, Ali ^a  

^a DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Combined glucose intolerance; Early phase insulin secretion; Impaired fasting glucose; Insulin resistance

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; ORAL GLUCOSE TOLERANCE TEST; STATISTICAL SIGNIFICANCE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 27744552296     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.52.531     Document Type: Article

References (29)

1. DeFronzo RA (1988) Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37: 667-687.
2. Porte D Jr (1991) Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 40: 16-180.
3. Fukushima M, Usami M, Ikeda M, Nakai Y, Taniguchi A, Matsuura T, Suzuki H, Kurose T, Yamada Y, Seino Y (2004) Insulin secretion and insulin sensitivity at different stages of glucose tolerance: A cross-sectional study of Japanese type 2 diabetes. Metabolism 53: 831-835.
4. Caumo A, Livio L (2004) First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab 287: E371-E385.
5. Alberti KGMM, Zimmet P (1988) Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 15: 539-553.
6. Unwin N, Shaw J, Zimmet P, Alberti KGMM (2002) Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention. Diabet Med 19: 708-723.
7. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS (1997) Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and World Health Organization diagnostic criteria. Diabetes Care 20: 1859-1862.
8. Festa A, D'Agostino R Jr, Hanley AJG, Karter AJ, Saad MF, Haffher SM (2004) Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or impaired fasting glucose. Diabetes 59: 1549-1555.
9. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen HC (1980) Coronary heart disease risk and impaired glucose tolerance: the Whitehall Study. Lancet 2: 1373-1376.
10. The DECODE study group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 21: 617-621.
11. Tominaga M, Eguchi H, Manaka H, Igarashi H, Kato T, Sekikawa A (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata Diabetes Study. Diabetes Care 22: 920-924.
12. Rodriguez BL, Curb JD, Burchfiel CM, Huang B, Sharp DS, Lu GY, Fujimoto W, Yano K (1996) Impaired glucose tolerance, diabetes and cardiovascular disease risk factor profiles: The Honolulu Heart Program. Diabetes Care 19: 587-590.
13. Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurkeschiev T (2003) Insulin secretion and insulin sensitivity pattern is different in isolated impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care 26: 868-874.
14. Prato SD (2003) Loss of early insulin secretion leads to postprandial hyperglycemia. Diabetologia 46 (Suppl 1): M2-M8.
15. DeFronzo RA, Bonadonna RC, Ferannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318-368.
16. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldaner JS, Kahn CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340: 925-929.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
18. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Ze MB, Monauni T, Muggeo M (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23: 57-63.
19. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modelling. Diabetes Care 27: 1487-1495.
20. Seltzer HS, Allen EW, Herron AL Jr, Brennan MT (1967) Insulin secretion in response to glycemic stimulus: Relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46: 323-335.
21. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326: 22-29.
22. Del Prato S, Marchetti P, Bonadonna RC (2002) Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes (Suppl 1): S109-S116.
23. Taylor R, Magnusson I, Rothman DL, Cline GW, Caumo A, Cobelli C, Shulman GI (1996) Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose haemostasis after a mixed meal in normal subjects. J Clin Invest 97: 126-132.
24. rdedition, Lippincott Williams and Wilkins, Philadelphia, USA: 1308-1309.
25. Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T, Groop LC (2000) Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from Botnia Study. Diabetes 49: 975-980.
26. Davies MJ, Raymond NT, Day JL, Hales C, Burden AC (2000) Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med 17: 433-440.
27. Hirose T, Mýzuno R, Yoshimoto T (2002) The effects of nateglinide following oral glucose load in impaired glucose tolerance subjects: Rapid insulin stimulation by nateglinide in IGT subjects. Endocr J 49: 649-652.
28. Uchino H, Niwa M, Shimizu T, Nishiyama K, Kawamori R (2000) Impairment of early insulin response after glucose load, rather than insulin resistance, is responsible for postprandial hyperglycemia seen in obese type 2 diabetes: assessment using nateglinide, a new insulin secretagogue. Endocr J 41: 639-641.
29. Torrens JI, Skurnick J, Davidow AL, Korenman SG, Santoro N, Soto-Greene M, Lasser N, Weiss G (2004) Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care 27: 354-361.